437 filings
6-K
CYTO
Altamira Therapeutics Ltd
16 May 24
Report of Foreign Private Issuer
4:15pm
20-F/A
2023 FY
CYTO
Altamira Therapeutics Ltd
22 Apr 24
Annual report (foreign) (amended)
4:31pm
EFFECT
CYTO
Altamira Therapeutics Ltd
18 Apr 24
Notice of effectiveness
12:15am
424B4
CYTO
Altamira Therapeutics Ltd
17 Apr 24
Prospectus supplement with pricing info
4:20pm
6-K
CYTO
Altamira Therapeutics Ltd
16 Apr 24
Notice of the Annual General Meeting of Shareholders
5:00pm
6-K
nzznln2l5dh8sz 4l1h
10 Apr 24
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
8:30am
S-8
svp3 ls4svr
10 Apr 24
Registration of securities for employees
8:15am
F-1
txtgjnd
10 Apr 24
Registration statement (foreign)
8:15am
424B4
bcvve9nx37rdqziy
22 Jan 24
Prospectus supplement with pricing info
5:02pm
EFFECT
eq0ekf
22 Jan 24
Notice of effectiveness
12:15am
6-K
cq4r lpqjs71nxqjc
19 Jan 24
Report of Foreign Private Issuer
4:45pm
424B5
6p4nir02qlt pa95rx
19 Jan 24
Prospectus supplement for primary offering
4:40pm
6-K
4aemo6pf0ajiz8
19 Jan 24
Report of Foreign Private Issuer
4:30pm
CORRESP
jy86o 3ep6xb6mfa
17 Jan 24
Correspondence with SEC
12:00am
UPLOAD
xpsp15fzw ku
16 Jan 24
Letter from SEC
12:00am
F-3
60gq4mz5 vs08iap
8 Jan 24
Shelf registration (foreign)
5:02pm
6-K
x3aed
11 Dec 23
Altamira Therapeutics Provides Investor and Business Update
8:01am
6-K
8qa1tp2j
11 Dec 23
Report of Foreign Private Issuer
8:00am
6-K
15b5x
8 Dec 23
Report of Foreign Private Issuer
9:00am